TAX-2

N/A

Report date: 2024/12/31 16:58:04
NME

Base Information

Drug NameTAX-2
Drug Alias NameAP-01AP-02TAX-2
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionImmunostimulantsThrombospondin 1 antagonistsPlatelet aggregation inhibitors +[4] 
TargetsInterferon gammaThrombospondin 1
Therapy Area/IndicationsSolid tumoursThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingaporeFrance
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCentre National De La Recherche Scientifique (Cnrs)University of Reims
China Registration ClassN/A

Develop Information

Active CompaniesApmonia Therapeutics SAS
Inactive CompaniesN/A
Active IndicationsSolid tumoursThrombosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A